Col NF

ORCID: 0000-0001-7106-662X · 1 paper in corpus

2009

American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.

Journal of Clinical Oncology ·doi:10.1200/jco.2008.20.5179

PURPOSE To update the 2002 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. METHODS A literature search identified relevant randomized trials published since 2002. Primary…